THROMBOSIS AND HAEMOSTASIS

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

THROMBOSIS AND HAEMOSTASIS

THROMB HAEMOSTASIS

ISSN / eISSN

0340-6245 / 2567-689X

目标和范围

Thrombosis and Haemostasis publishes reports on basic, translational and clinical research dedicated to novel results and highest quality in any area of thrombosis and haemostasis, vascular biology and medicine, inflammation and infection, platelet and leukocyte biology, from genetic, molecular & cellular studies, diagnostic, therapeutic & preventative studies to high-level translational and clinical research. The journal provides position and guideline papers, state-of-the-art papers, expert analysis and commentaries, and dedicated theme issues covering recent developments and key topics in the field.

研究方向

血液学

外周血管病

CiteScore

10.50

查看趋势图

CiteScore 学科排名

类别	分区	排名
Medicine - Hematology	Q1	#15/129

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
HEMATOLOGY - SCIE	Q1
PERIPHERAL VASCULAR DISEASE - SCIE	Q1

H-index

178

出版国家或地区

GERMANY

出版商

Schattauer GmbH

出版周期

Monthly

出版年份

1976

年文章数

137

Open Access

通讯方式

SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN, HOLDERLINSTRASSE 3, STUTTGART, GERMANY, D-70174

同领域相关热门期刊
近期发表文章

Protease-activated receptor-1 IgG autoantibodies in patients with COVID-19: (2023) Leander Reinshagen, Vanasa Nageswaran, Harald Heidecke, Kai Schulze-Forster, Anne-Christin Beatrice Wilde, Pegah Ramezani Rad, Wolfgang Poller, Erik A...

Persistent and late-onset disseminated intravascular coagulation is closely related to poor prognosis in patients with sepsis: (2023) Tadashi Matsuoka, Kazuma Yamakawa, Toshiaki Iba, Koichiro Homma, Junichi Sasaki

Sex as a Risk Factor for Atrial Fibrillation-Related Stroke: (2023) Bernadette Corica, Trudie Lobban, Mellanie True Hills, Marco Proietti, Giulio Francesco Romiti

Proteomic characterization of plasma in Lemierre´s syndrome: (2023) David Nygren, Gustav Torisson, Lotta Happonen, Lisa Mellhammar, Adam Linder, Johan Elf, Hong Yan, Charlotte Welinder, Karin Holm

Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction: (2023) Oliver Buchhave Pedersen, Anne-Mette Hvas, Leonardo Pasalic, Steen Dalby Kristensen, Erik Lerkevang Grove, Peter H. Nissen

Factor Xa Inhibitor Plasma Concentrations and Clinical Outcomes in Patients Weighing ≤50 kg—Experience from Four UK Centers: (2023) Victoria Speed, Rachel Clapham, John Bartoli-Abdou, Katherine Stirling, Frances Akor, Victoria Collings, Rachna Patel, Rosalind Byrne, Roopen Arya, Ji...

Differential Effects of Erythropoietin Administration and Overexpression on Venous Thrombosis in Mice: (2023) Sven Stockhausen, Badr Kilani, Irene Schubert, Anna-Lena Steinsiek, Sue Chandraratne, Franziska Wendler, Luke Eivers, Marie-Luise von Brühl, Steffen M...

Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency.: (2023) Patricia Sigüenza, Juan José López Núñez, Concepción Falga Tirado, Covadonga Gómez-Cuervo, Antoni Riera-Mestre, Aída GIL-DÍAZ, Peter Verhamme, Ana Cri...

Dual antiplatelet (DAPT) or Dual Pathway Inhibition (DPI): (2023) Shinya Goto, Shinichi Goto

Platelet activation is upregulated in cirrhotic patients with portal vein thrombosis: (2023) Jingnuo Ding, Fazhi Zhao, Juanjuan Cui, Mingqing Zhu, weifeng zhao

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

In the first trial, it took one and a half months for major revisions. Three months later, after the major revisions were returned, there was a minor revision within a month (a protein was incorrectly depicted in the last figure). After the minor revision, it was still incorrect, and it took two more times to finally be accepted. It took a month for back and forth minor revisions. In conclusion, the review experts were very professional. Going through one round of major revisions was a significant improvement and greatly enhanced one's scientific thinking.

2021-09-07

查看所有评论

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started